Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Infect Dis ; 180(4): 1010-7, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10479125

RESUMEN

We examined human herpesvirus 8 (HHV-8) seroprevalence and seroincidence among 245 homosexual men from New York City (NYC) and Washington, DC (DC) who have been followed since 1982. An immunofluorescence assay measured antibodies to a latent HHV-8 nuclear antigen. Seroprevalence was 20.4% in 1982; seroincidence was approximately 15%/year during 1982-1983 but fell sharply thereafter. NYC men had a higher seroprevalence (odds ratio, 3.43; P<.001) and seroincidence (rate ratio, 2.13; P=.01) than DC men. Risk of Kaposi's sarcoma (KS) was increased in seropositive men (adjusted relative hazard, 3.58; P=.02). Among men who were seropositive for both human immunodeficiency virus type 1 and HHV-8, the 10-year cumulative risk of KS was 39%; time from coinfection to KS diagnosis ranged from 15 to 154 months (median, 63.5 months). This study shows an epidemic of HHV-8 among US homosexual men in the early 1980s that was associated with a high risk of developing KS.


Asunto(s)
Infecciones por VIH/epidemiología , Infecciones por Herpesviridae/epidemiología , Herpesvirus Humano 8 , Homosexualidad Masculina/estadística & datos numéricos , Sarcoma de Kaposi/epidemiología , Anticuerpos Antivirales/sangre , Comorbilidad , District of Columbia , Estudios de Seguimiento , Infecciones por VIH/inmunología , Seropositividad para VIH/epidemiología , Seropositividad para VIH/inmunología , VIH-1 , Infecciones por Herpesviridae/inmunología , Humanos , Incidencia , Masculino , Ciudad de Nueva York/epidemiología , Oportunidad Relativa , Prevalencia , Factores de Riesgo , Sarcoma de Kaposi/inmunología , Factores de Tiempo
2.
Blood ; 91(3): 870-8, 1998 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-9446647

RESUMEN

Cytokine receptors have been shown in cell culture systems to use phosphotyrosine residues as docking sites for certain signal transduction intermediates. Studies using various cellular backgrounds have yielded conflicting information about the importance of such residues. The present studies were undertaken to determine whether or not tyrosine residues within the erythropoietin receptor (EPOR) are essential for biologic activity during hematopoiesis in vivo. A variant of the EPOR was constructed that contains both a substitution (R129C) causing constitutive receptor activation as well as replacement of all eight cytoplasmic tyrosines by phenylalanines (cEPORYF). A comparison between animals exposed to recombinant retroviruses expressing cEPOR and cEPORYF showed that efficient red blood cell (RBC) development in vivo is dependent on the pressence of tyrosine residues in the cytoplasmic domain of the EPOR. In addition, an inefficient EPOR tyrosine independent pathway supporting RBC development was detected. Tyrosine add-back mutants showed that multiple individual tyrosines have the capacity to restore full erythropoietic potential to the EPOR as determined in whole animals. The analysis of primary erythroid progenitors transduced with the various cEPOR tyrosine mutants and tyrosine add-backs showed that only tyrosine 343 (Y1) and tyrosine 479 (Y8) were capable of supporting immature burst-forming unit-erythroid progenitor development. Thus, this receptor is characterized by striking functional redundancy of tyrosines in a biologically relevant context. However, selective tyrosine residues may be uniquely important for early signals supporting erythroid development.


Asunto(s)
Eritropoyesis , Receptores de Eritropoyetina/química , Tirosina/fisiología , Animales , Línea Celular , Eritropoyetina/farmacología , Expresión Génica , Técnicas de Transferencia de Gen , Ratones , Mutagénesis , Fenilalanina , Receptores de Eritropoyetina/genética , Proteínas Recombinantes , Retroviridae/genética , Transducción de Señal , Relación Estructura-Actividad
3.
J Biol Chem ; 272(31): 19625-31, 1997 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-9235971

RESUMEN

The present studies analyzed the biologic activity of a gene product (vIL-6) encoded by the recently discovered Kaposi's sarcoma-associated herpesvirus (KSHV) bearing 24.8% amino acid identity with human interleukin-6 (huIL-6). Based on this similarity, we hypothesized that this viral homolog might trigger the JAK/STAT pathway, which typically is engaged by IL-6 and other cytokines. Activation of receptor-associated Janus tyrosine kinases (JAKs) results in the subsequent phosphorylation of signal transducers and activators of transcription (STATs) leading to nuclear entry and transcriptional regulation of target genes. Treatment of HepG2 cells with culture medium containing recombinant KSHV-encoded vIL-6 led to rapid induction of JAK1 phosphorylation and a nuclear DNA-binding activity found to contain STAT1 and STAT3. An antibody to the IL-6 receptor (IL-6R) alpha subunit effectively neutralized the response to huIL-6 but failed to block STAT activation by vIL-6. In contrast, an antibody reactive with the gp130 subunit of IL-6R abrogated signaling of both responses. Moreover, a transfected cell line expressing human gp130 without IL-6Ralpha exhibited a robust response to vIL-6 but not to huIL-6. These results demonstrate that KSHV encodes a cytokine that activates specific JAK/STAT signaling via interactions with the gp130 signal transducing subunit independently of the IL-6Ralpha chain. This activity may have an impact on gp130-mediated signaling in response to native cytokines and thereby influence disease pathogenesis upon KSHV infection.


Asunto(s)
Antígenos CD/fisiología , Herpesvirus Humano 8/fisiología , Interleucina-6/farmacología , Receptores de Interleucina/fisiología , Proteínas Virales/farmacología , Células Cultivadas , Proteínas de Unión al ADN/fisiología , Humanos , Receptores de Interleucina-6 , Factor de Transcripción STAT3 , Transducción de Señal , Acetato de Tetradecanoilforbol/farmacología , Transactivadores/fisiología , Transcripción Genética
4.
J Clin Invest ; 99(2): 169-77, 1997 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-9005984

RESUMEN

Genetic evidence suggests that mutations in the gamma(c) receptor subunit cause X-linked severe combined immunodeficiency (X-SCID). The gamma(c) subunit can be employed in receptor complexes for IL-2, -4, -7, -9, and -15, and the multiple signaling defects that would result from a defective gamma(c) chain in these receptors are proposed to cause the severe phenotype of X-SCID patients. Interestingly, gene disruption of either IL-7 or the IL-7 receptor (IL-7R) alpha subunit in mice leads to immunological defects that are similar to human X-SCID. These observations suggest the functional importance of gamma(c) in the IL-7R complex. In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function. Nonetheless, only a limited portion of the cytoplasmic domain of gamma(c) is necessary for IL-7R signal transduction. Furthermore, replacement of the gamma(c) cytoplasmic domain by a severely truncated erythropoeitin receptor does not affect measured IL-7R signaling events. These findings support a model in which gamma(c) serves primarily to activate signal transduction by the IL-7R complex, while IL-7R alpha determines specific signaling events through its association with cytoplasmic signaling molecules. Finally, these studies are consistent with the hypothesis that the molecular pathogenesis of X-SCID is due primarily to gamma(c)-mediated defects in the IL-7/IL-7R system.


Asunto(s)
Antígenos CD/metabolismo , Receptores de Interleucina/metabolismo , Inmunodeficiencia Combinada Grave/etiología , Inmunodeficiencia Combinada Grave/genética , Cromosoma X/genética , Antígenos CD/química , Linfocitos B/efectos de los fármacos , Polaridad Celular , Citocinas/farmacología , Proteínas de Unión al ADN/metabolismo , Dimerización , Ligamiento Genético , Humanos , Conformación Proteica , Proteínas Tirosina Quinasas/metabolismo , Receptores de Interleucina/química , Receptores de Interleucina-7 , Transducción de Señal , Relación Estructura-Actividad , Factores de Transcripción/metabolismo
5.
EMBO J ; 15(17): 4506-14, 1996 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-8887542

RESUMEN

Interleukin-4 (IL-4) exerts its effects through a heterodimeric receptor complex (IL-4R), which contains the IL-4R(alpha) and gamma(c) subunits. IL-4R(alpha) also functions with other partner subunits in several receptor types, including the IL-13 receptor. To examine the roles of the individual subunits within IL-4R complexes, we employed a chimeric system that recapitulates native IL-4R function as verified by the activation of the kinases, JAK1 and JAK3, and induction of STAT-6. When a mutant gamma(c) subunit in which the four cytoplasmic tyrosines were converted to phenylalanine was paired with the cytoplasmic domain of the IL-4R(alpha) chain, specificity within the JAK-STAT pathway was not altered. Signaling events were examined further in cells expressing the IL-4R(alpha) chimera alone without the gamma(c) chimera. Ligand-induced homodimerization of these receptors activated the IL-4 signaling program despite the absence of gamma(c), including induction of JAK1 and STAT-6, phosphorylation of the insulin-related substrate 1 and cellular proliferation. Thus, homotypic interactions of the IL-4R(alpha) subunit are sufficient for the initiation and determination of IL-4-specific signaling events, and such interactions may be integral to signaling through IL-4R complexes.


Asunto(s)
Antígenos CD/metabolismo , Interleucina-4/metabolismo , Receptores de Interleucina/metabolismo , Transducción de Señal , Animales , Antígenos CD/química , Línea Celular , Activación Enzimática , Proteínas Sustrato del Receptor de Insulina , Janus Quinasa 1 , Janus Quinasa 3 , Ratones , Fosfoproteínas/metabolismo , Fosforilación , Proteínas Tirosina Quinasas/metabolismo , Receptores de Interleucina/química , Receptores de Interleucina-4 , Proteínas Recombinantes de Fusión/metabolismo , Tirosina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA